OppenheimerFunds’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$97.9M	Buy	3,644,406 +15,830	+0.4%	+$370K	0.12%	173
2018 Q4	$58.7M	Sell	3,628,576 -85,390	-2%	-$1.66M	0.08%	240
2018 Q3	$77.1M	Sell	3,713,966 -744,410	-17%	-$11.7M	0.09%	245
2018 Q2	$68.1M	Buy	4,458,376 +112,430	+3%	+$2M	0.08%	268
2018 Q1	$97.7M	Sell	4,345,946 -467,153	-10%	-$12.9M	0.12%	186
2017 Q4	$145M	Sell	4,813,099 -325,374	-6%	-$10.4M	0.18%	145
2017 Q3	$194M	Buy	5,138,473 +63,873	+1%	+$2.08M	0.24%	112
2017 Q2	$142M	Buy	5,074,600 +156,314	+3%	+$4.66M	0.17%	150
2017 Q1	$169M	Buy	4,918,286 +170,289	+4%	+$6.01M	0.2%	132
2016 Q4	$137M	Sell	4,747,997 -402,226	-8%	-$10.6M	0.17%	148
2016 Q3	$164M	Buy	5,150,223 +158,572	+3%	+$5.38M	0.21%	131
2016 Q2	$162M	Buy	4,991,651 +359,960	+8%	+$12M	0.21%	125
2016 Q1	$130M	Buy	4,631,691 +703,256	+18%	+$15.3M	0.17%	146
2015 Q4	$140M	Buy	3,928,435 +211,963	+6%	+$7.47M	0.18%	136
2015 Q3	$123M	Sell	3,716,472 -63,326	-2%	-$2.63M	0.17%	156
2015 Q2	$158M	Buy	3,779,798 +70,291	+2%	+$2.72M	0.18%	145
2015 Q1	$121M	Buy	+3,709,507	New	+$128M	0.14%	192